AMGEVITA Trademark

Trademark Overview


On Tuesday, September 24, 2019, a trademark application was filed for AMGEVITA with the United States Patent and Trademark Office. The USPTO has given the AMGEVITA trademark a serial number of 88628763. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, May 1, 2023. This trademark is owned by Amgen Inc.. The AMGEVITA trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations and substances used for the treatment of bone, joint, intestine, colon, skin, lung, eye, bladder, blood cells, and blood vessel diseases and disorders; pharmaceutical preparations and substances for the treatment of autoimmune and immune system, inflammatory, inflammatory bowel, gastrointestinal, musculoskeletal, dermatological, pulmonary, respiratory, oncological, and ophthalmic diseases and disorders; pharmaceutical preparations and substances used for the treatment of arthritis, rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis, axial spondyloarthritis, juvenile idiopathic arthritis, enthesitis related arthritis, osteoarthritis, peripheral spondyloarthritis, acute disc prolapse, inflammatory bowel disease, Crohn's disease, ulcerative colitis, Intestinal Behçet's Disease, chronic pouchitis, small bowel lesions, Hermansky-Pudlak syndrome, psoriasis, psoriasis vulgaris, psoriasis arthropica, plaque psoriasis, hidradenitis suppurativa, inters...
amgevita

General Information


Serial Number88628763
Word MarkAMGEVITA
Filing DateTuesday, September 24, 2019
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, May 1, 2023
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, February 4, 2020

Trademark Statements


Goods and ServicesPharmaceutical preparations and substances used for the treatment of bone, joint, intestine, colon, skin, lung, eye, bladder, blood cells, and blood vessel diseases and disorders; pharmaceutical preparations and substances for the treatment of autoimmune and immune system, inflammatory, inflammatory bowel, gastrointestinal, musculoskeletal, dermatological, pulmonary, respiratory, oncological, and ophthalmic diseases and disorders; pharmaceutical preparations and substances used for the treatment of arthritis, rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis, axial spondyloarthritis, juvenile idiopathic arthritis, enthesitis related arthritis, osteoarthritis, peripheral spondyloarthritis, acute disc prolapse, inflammatory bowel disease, Crohn's disease, ulcerative colitis, Intestinal Behçet's Disease, chronic pouchitis, small bowel lesions, Hermansky-Pudlak syndrome, psoriasis, psoriasis vulgaris, psoriasis arthropica, plaque psoriasis, hidradenitis suppurativa, interstitial cystitis, sleep apnea, sarcoidosis, retinal vascular disorders, uveitis, choroidal neovascularization, Pyoderma Gangrenosum, giant cell arteritis, Netherton syndrome, anaplastic thyroid cancers, asthma, and refractory asthma

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateSaturday, September 28, 2019
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameAmgen Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressThousand Oaks, CA 913201799

Party NameAmgen Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressThousand Oaks, CA 913201799

Trademark Events


Event DateEvent Description
Monday, May 1, 2023ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Monday, May 1, 2023ABANDONMENT - NO USE STATEMENT FILED
Friday, September 9, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, September 8, 2022SOU EXTENSION 5 GRANTED
Monday, August 29, 2022SOU EXTENSION 5 FILED
Thursday, September 8, 2022CASE ASSIGNED TO INTENT TO USE PARALEGAL
Monday, August 29, 2022TEAS EXTENSION RECEIVED
Friday, February 18, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, February 16, 2022SOU EXTENSION 4 GRANTED
Wednesday, February 16, 2022SOU EXTENSION 4 FILED
Wednesday, February 16, 2022TEAS EXTENSION RECEIVED
Saturday, August 14, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, August 12, 2021SOU EXTENSION 3 GRANTED
Thursday, August 12, 2021SOU EXTENSION 3 FILED
Thursday, August 12, 2021TEAS EXTENSION RECEIVED
Tuesday, March 23, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, March 19, 2021SOU EXTENSION 2 GRANTED
Friday, March 19, 2021SOU EXTENSION 2 FILED
Friday, March 19, 2021TEAS EXTENSION RECEIVED
Tuesday, September 22, 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, September 18, 2020SOU EXTENSION 1 GRANTED
Friday, September 18, 2020SOU EXTENSION 1 FILED
Friday, September 18, 2020TEAS EXTENSION RECEIVED
Tuesday, March 31, 2020NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, February 4, 2020OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, February 4, 2020PUBLISHED FOR OPPOSITION
Wednesday, January 15, 2020NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Thursday, December 26, 2019APPROVED FOR PUB - PRINCIPAL REGISTER
Thursday, December 26, 2019ASSIGNED TO EXAMINER
Saturday, September 28, 2019NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Friday, September 27, 2019NEW APPLICATION ENTERED